Skip to content
10-Q

Quarterly Report

DIAMEDICA THERAPEUTICS INC. DMAC

0001437749-25-016488

← back to feed
Filed
May 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 9, 2025 42.88M sh
Cash And Equivalents Q1 2025 · Mar 31, 2025 $2.59M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $3.03M
Current Liabilities Q1 2025 · Mar 31, 2025 $4.67M
Current Liabilities Q1 2025 · Dec 31, 2024 $5.39M
Current Assets Q1 2025 · Mar 31, 2025 $37.42M
Current Assets Q1 2025 · Dec 31, 2024 $44.61M
Total Assets Q1 2025 · Mar 31, 2025 $38.83M
Total Assets Q1 2025 · Dec 31, 2024 $46.35M
Capex Q1 2025 · Mar 31, 2024 $9K
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$6.65M
Stockholders Equity Q1 2025 · Mar 31, 2024 $46.35M
Stockholders Equity Q1 2025 · Dec 31, 2023 $51.06M
Eps Basic Q1 2025 · Mar 31, 2024 −$0.14
Sga Expense Q1 2025 · Mar 31, 2024 $2.07M
Rd Expense Q1 2025 · Mar 31, 2024 $3.68M
Net Income Q1 2025 · Mar 31, 2024 −$5.15M
Operating Income Q1 2025 · Mar 31, 2024 −$5.74M